z-logo
open-access-imgOpen Access
Alpha-foetoprotein producing endometrial serous carcinoma
Author(s) -
Rashpal Flora,
Suraiya Dubash,
Alexandra Taylor,
Mona El-Bahawy
Publication year - 2011
Publication title -
journal of solid tumors
Language(s) - English
Resource type - Journals
eISSN - 1925-4075
pISSN - 1925-4067
DOI - 10.5430/jst.v1n2p83
Subject(s) - medicine , serous fluid , serous carcinoma , carcinoma , alpha fetoprotein , yolk sac , alpha (finance) , germ cell tumors , gynecology , pathology , gastroenterology , cancer , surgery , embryo , biology , ovarian cancer , hepatocellular carcinoma , construct validity , chemotherapy , patient satisfaction , microbiology and biotechnology

Elevated serum levels of alpha-fetoprotein, a fetal serum protein, occurs on development of hepatoma or germ cell tumors, mainly yolk sac tumor.  Very few cases of endometrial carcinoma associated with elevated serum alpha-fetoprotein have been reported.  It is important to be aware of such entities to ensure correct diagnosis and hence patient management. We report a case of a 71 years old lady presenting with postmenopausal bleeding and elevated serum alpha-fetoprotein.  Investigations confirmed the patient had an alpha-fetoprotein producing endometrial serous carcinoma.  This is the third case of alpha-foetoprotein producing serous carcinoma.  We discuss the clinicopathological features of the case and review the literature for previously reported alpha-fetoprotein producing endometrial carcinomas.  These cases show aggressive behavior and very poor prognosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here